| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.9 |
| mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |